FDA recall D-0866-2026

Product

Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.

Reason for recall

Superpotent Drug

Distribution

US Nationwide.

Key facts

Status

Ongoing

Initiation date

2026-08-21

Report date

2026-09-23

Voluntary/Mandated

Voluntary: Firm initiated

Location

Auburn, AL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0866-2026